If you’ve thought about losing weight lately, you’re not alone. And you’re far from the first guy to look up the best weight ...

Eli Lilly said on Wednesday patients on obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's ...

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

Losing weight can be difficult for many reasons, including your genetics, hormones, metabolism, lifestyle factors, and mental ...

In a landmark trial, Eli Lilly's obesity drug Zepbound surpassed Novo Nordisk's Wegovy, showing 47% more weight loss. The ...

Wegovy was approved in the US as a treatment for heart disease in March, while Zepbound is expected to be given the green ...

A rival drug company is celebrating results claiming its drug helps patients lose more weight than Novo Nordisk’s Wegovy. Eli ...

Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust ...

The prevalence of MASLD (metabolic dysfunction-associated steatotic liver disease) is exploding in most regions of the world, ...

It’s made in laboratories, not grown on farmland or cultivated in a greenhouse. It’s relatively cheap. It has medicinal powers. It was enshrined in popular culture by the critically acclaimed ...

Research has shown that obstructive sleep apnea is an independent risk factor for depression, anxiety, and, more importantly, ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. Type 1 diabetes develops when the body destroys its own insulin-producing cells.